With Enemies Like These: Will the Democrats Make Part D More Pharma Friendly?

The Democratic leadership rammed a major health bill through the House this summer, including some Medicare Part D fixes that read like a Big Pharma wish list. Have the industry's toughest critics gone soft?

Michael McCaughan

When Big Pharma executives looked at House Speaker Nancy Pelosi’s agenda for 2007, they didn’t see this coming.

More from Market Access

More from Pink Sheet